Joseph M. Still Research Foundation, Inc. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00295178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

JOSEPH M STILL RESEARCH FOUNDATION | Joseph M. Still Research Foundation, Inc.

Active Ingredients

Drugs in Phase 4 Trials (3)

daptomycin (cubicin) (1 trial)

vancomycin (Vancocin) (1 trial)

vitamin k (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 4)

Cellulitis (Phase 4)

Erysipelas (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3